Balaxi Pharmaceuticals Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 79.69 | ||||
| Other Income Qtr Cr | -0.99 | ||||
| Operating Revenues Qtr | 80.68 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 76.02 | ||||
Operating Profit Qtr | 4.66 | ||||
EBITDA Qtr Cr | 3.67 | ||||
Depreciation Qtr | 0.85 | ||||
Net Profit Qtr | 1.30 | ||||
Basic EPS Qtr | 0.24 | ||||